Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 7—July 2023
Research Letter

Isolation of Elizabethkingia spp. from Diagnostic Specimens from Dogs and Cats, United States, 2019–2021

J. Scott WeeseComments to Author , Kurtis E. Sobkowich, Zvonimir Poljak, and Theresa M. Bernardo
Author affiliation: University of Guelph, Guelph, Ontario, Canada

Main Article

Table 2

Antimicrobial susceptibility of Elizabethkingia spp. isolated from 71 dog and 15 cat diagnostic specimens, United States, 2019–2021*

Antimicrobial drug No. tested No. (%) susceptible
Amikacin 84 13 (15)
Amoxicillin 57 4 (7.0)
Amoxicillin-clavulanic acid 57 5 (8.8)
Cefotaxime 46 6 (13)
Cefovecin 57 5 (8.8)
Cefpodoxime 57 7 (12)
Ceftazidime 86 6 (7.0)
Ceftiofur 53 9 (17)
Cephalexin 57 3 (5.3)
Chloramphenicol 64 9 (14)
Doxycycline 59 39 (66)
Enrofloxacin 86 73 (85)
Gentamicin 85 17 (20)
Imipenem 86 7 (8.1)
Marbofloxacin 86 75 (87)
Trimethoprim/sulfamethoxazole 54 48 (89)

*Antimicrobial susceptibility testing performed according to Clinical and Laboratory Standards Institute guidelines (7) at IDEXX Laboratories (https://www.idexx.com).

Main Article

References
  1. Dziuban  EJ, Franks  JL, So  M, Peacock  G, Blaney  DD. Elizabethkingia in children: a comprehensive review of symptomatic cases reported from 1944 to 2017. Clin Infect Dis. 2018;67:1449. DOIPubMedGoogle Scholar
  2. US Centers for Disease Control and Prevention. About Elizabethkingia [cited 2022 Dec 16]. https://www.cdc.gov/elizabethkingia/about/index.html
  3. Lau  SK, Chow  WN, Foo  CH, Curreem  SO, Lo  GC, Teng  JL, et al. Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality. Sci Rep. 2016;6:26045. DOIPubMedGoogle Scholar
  4. Lee  DH, Patel  RH, Mehra  I, Shenoy  R, Nanjappa  S, Greene  J. A case series of Elizabethkingia meningosepticum bacteremia in the cancer population. Cureus. 2021;13:e18627. DOIPubMedGoogle Scholar
  5. Bordelo  J, Viegas  C, Coelho  C, Poeta  P. First report of bacteremia caused by Elizabethkingia meningoseptica in a dog. Can Vet J. 2016;57:994.PubMedGoogle Scholar
  6. Johnson  WL, Ramachandran  A, Torres  NJ, Nicholson  AC, Whitney  AM, Bell  M, et al. The draft genomes of Elizabethkingia anophelis of equine origin are genetically similar to three isolates from human clinical specimens. PLoS One. 2018;13:e0200731. DOIPubMedGoogle Scholar
  7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; thirty-first informational supplement (M100-S31). Wayne (PA): The Institute; 2021.
  8. Perrin  A, Larsonneur  E, Nicholson  AC, Edwards  DJ, Gundlach  KM, Whitney  AM, et al. Evolutionary dynamics and genomic features of the Elizabethkingia anophelis 2015 to 2016 Wisconsin outbreak strain. Nat Commun. 2017;8:15483. DOIPubMedGoogle Scholar
  9. Hu  R, Zhang  Q, Gu  Z. Whole-genome analysis of the potentially zoonotic Elizabethkingia miricola FL160902 with two new chromosomal MBL gene variants. J Antimicrob Chemother. 2020;75:52630. DOIPubMedGoogle Scholar
  10. Comba  IY, Schuetz  AN, Misra  A, Friedman  DZP, Stevens  R, Patel  R, et al. Antimicrobial susceptibility of Elizabethkingia species: report from a reference laboratory. J Clin Microbiol. 2022;60:e0254121. DOIPubMedGoogle Scholar

Main Article

Page created: May 23, 2023
Page updated: June 21, 2023
Page reviewed: June 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external